Articles by James Calloway
IBM Stock Rebounds as $10.9B Cash Flow Target Looms
IBM shares recovered 3.65% on Friday to $214.19, but the company faces a $10.9 billion free cash flow challenge in the second half after a weak Q2.
Western Digital Posts Weekly Gain Despite Friday Slide as Profit Outlook Brightens
Western Digital closed Friday at $519.80, down 6.9%, yet still gained 8.9% for the week as profit estimates climbed 20% to $3.30 per share.
Viking Therapeutics Faces Cash Runway Questions Ahead of Q2 Report
Viking Therapeutics shares fell 6.2% last week as analysts increased Q2 loss estimates by 24% to $1.23 per share. The company's cash runway faces scrutiny ahead of earnings on July 29.
Meta Shares See $44 Swing as AI Spending, Ad Trial Loom
Meta Platforms shares slid 1.8% on Friday, with options implying a $44 swing after earnings. The company faces a high capex ratio and a critical advertising trial.
PayPal Stock Holds Nearly 67% of Takeover Premium Ahead of Q2 Earnings
PayPal shares retained 66.9% of the bid premium from a reported $60.50 takeover offer ahead of Q2 earnings, closing Friday at $56.15.
Nokia Stock Tumbles 10% Despite AI Order Surge and Profit Beat
Nokia shares fell 10.3% over Thursday and Friday, closing at €8.222, despite Q2 comparable operating profit exceeding expectations by 13.6% and AI/cloud orders reaching €2.8 billion.
United Airlines Shares Flat Despite Bullish 2026 Guidance: No Premium Yet
United Airlines (UAL) shares rose 2.5% on Friday but remain flat on the week after updating 2026 guidance. The stock trades at 11.8x EPS midpoint, below Delta and Southwest.
Rivian Stock Hovers Near Offering Price Ahead of Q2 Earnings
Rivian (RIVN) shares closed Friday at $15.84, only 2.2% above the recent $15.50 offering price, as the market awaits Q2 earnings with key focus on R2 production and cash burn.
Teva Q2 Preview: Emalex Charge May Mask Underlying Progress
Teva's Q2 results face a $700M Emalex charge that could neutralize branded-drug growth, with consensus EPS near zero. Revenue is forecast at $4.058B.
Microsoft's $40B AI Spend Under Microscope as Earnings Loom
Microsoft heads into earnings with a $40 billion capex target, raising questions about AI investment returns. Azure growth and cash conversion are key metrics.